ClinicalTrials.gov record
A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease
ClinicalTrials.gov ID: NCT00134173
Public ClinicalTrials.gov record NCT00134173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3, Multi-Center, Double-Blind, Randomized, Parallel Group, Coronary Artery Intravascular Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety, and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Atorvastatin Alone, in Subjects With Angiographically Documented Coronary Heart Disease.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Torcetrapib project was terminated on December 2, 2006 due to safety findings. To look at ultrasound images taken in the blood vessels of the heart and to look at various lipids in the blood of people with known coronary heart disease
Study identification
- NCT ID
- NCT00134173
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,100 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2003 (Type not available)
- Primary completion
- Not listed
- Completion
- Sep 2006 (Actual)
- Last update posted
- Dec 10, 2007
2003 – 2006
United States locations
- U.S. sites
- 127
- U.S. states
- 34
- U.S. cities
- 127
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | — | — |
| Pfizer Investigational Site | Mobile | Alabama | — | — |
| Pfizer Investigational Site | Little Rock | Arkansas | — | — |
| Pfizer Investigational Site | Fresno | California | — | — |
| Pfizer Investigational Site | Los Altos | California | — | — |
| Pfizer Investigational Site | Los Angeles | California | — | — |
| Pfizer Investigational Site | Mountain View | California | — | — |
| Pfizer Investigational Site | Sacramento | California | — | — |
| Pfizer Investigational Site | San Diego | California | — | — |
| Pfizer Investigational Site | San Francisco | California | — | — |
| Pfizer Investigational Site | Santa Rosa | California | — | — |
| Pfizer Investigational Site | Stockton | California | — | — |
| Pfizer Investigational Site | Boulder | Colorado | — | — |
| Pfizer Investigational Site | Denver | Colorado | — | — |
| Pfizer Investigational Site | Brandford | Connecticut | — | — |
| Pfizer Investigational Site | Farmington | Connecticut | — | — |
| Pfizer Investigational Site | Guilford | Connecticut | — | — |
| Pfizer Investigational Site | New Haven | Connecticut | — | — |
| Pfizer Investigational Site | Atlantis | Florida | — | — |
| Pfizer Investigational Site | Clearwater | Florida | — | — |
| Pfizer Investigational Site | Dunedin | Florida | — | — |
| Pfizer Investigational Site | Fort Lauderdale | Florida | — | — |
| Pfizer Investigational Site | Jacksonville | Florida | — | — |
| Pfizer Investigational Site | Largo | Florida | — | — |
| Pfizer Investigational Site | Melbourne | Florida | — | — |
| Pfizer Investigational Site | Miami | Florida | — | — |
| Pfizer Investigational Site | Orlando | Florida | — | — |
| Pfizer Investigational Site | Pensacola | Florida | — | — |
| Pfizer Investigational Site | Safety Harbor | Florida | — | — |
| Pfizer Investigational Site | Sarasota | Florida | — | — |
| Pfizer Investigational Site | Tampa | Florida | — | — |
| Pfizer Investigational Site | Blue Island | Illinois | — | — |
| Pfizer Investigational Site | Merrionette Park | Illinois | — | — |
| Pfizer Investigational Site | Rockford | Illinois | — | — |
| Pfizer Investigational Site | Elkhart | Indiana | — | — |
| Pfizer Investigational Site | Goshen | Indiana | — | — |
| Pfizer Investigational Site | Hobart | Indiana | — | — |
| Pfizer Investigational Site | Merrillville | Indiana | — | — |
| Pfizer Investigational Site | Davenport | Iowa | — | — |
| Pfizer Investigational Site | Des Moines | Iowa | — | — |
| Pfizer Investigational Site | West Des Moines | Iowa | — | — |
| Pfizer Investigational Site | Shawnee Mission | Kansas | — | — |
| Pfizer Investigational Site | Louisville | Kentucky | — | — |
| Pfizer Investigational Site | Bogalusa | Louisiana | — | — |
| Pfizer Investigational Site | Covington | Louisiana | — | — |
| Pfizer Investigational Site | New Orleans | Louisiana | — | — |
| Pfizer Investigational Site | Auburn | Maine | — | — |
| Pfizer Investigational Site | Lewiston | Maine | — | — |
| Pfizer Investigational Site | Portland | Maine | — | — |
| Pfizer Investigational Site | Scarborough | Maine | — | — |
| Pfizer Investigational Site | Baltimore | Maryland | — | — |
| Pfizer Investigational Site | Columbia | Maryland | — | — |
| Pfizer Investigational Site | Salisbury | Maryland | — | — |
| Pfizer Investigational Site | Takoma Park | Maryland | — | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | — | — |
| Pfizer Investigational Site | Flint | Michigan | — | — |
| Pfizer Investigational Site | Kalamazoo | Michigan | — | — |
| Pfizer Investigational Site | Lapeer | Michigan | — | — |
| Pfizer Investigational Site | Petoskey | Michigan | — | — |
| Pfizer Investigational Site | Royal Oak | Michigan | — | — |
| Pfizer Investigational Site | Saginaw | Michigan | — | — |
| Pfizer Investigational Site | Ypsilanti | Michigan | — | — |
| Pfizer Investigational Site | Duluth | Minnesota | — | — |
| Pfizer Investigational Site | Maplewood | Minnesota | — | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | — | — |
| Pfizer Investigational Site | Saint Cloud | Minnesota | — | — |
| Pfizer Investigational Site | Saint Paul | Minnesota | — | — |
| Pfizer Investigational Site | Southaven | Mississippi | — | — |
| Pfizer Investigational Site | Kansas City | Missouri | — | — |
| Pfizer Investigational Site | Omaha | Nebraska | — | — |
| Pfizer Investigational Site | Ridgewood | New Jersey | — | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | — | — |
| Pfizer Investigational Site | Carlsbad | New Mexico | — | — |
| Pfizer Investigational Site | Albany | New York | — | — |
| Pfizer Investigational Site | Bay Shore | New York | — | — |
| Pfizer Investigational Site | Buffalo | New York | — | — |
| Pfizer Investigational Site | Flushing | New York | — | — |
| Pfizer Investigational Site | Johnson City | New York | — | — |
| Pfizer Investigational Site | New York | New York | — | — |
| Pfizer Investigational Site | Oneonta | New York | — | — |
| Pfizer Investigational Site | Poughkeepsie | New York | — | — |
| Pfizer Investigational Site | Rochester | New York | — | — |
| Pfizer Investigational Site | Troy | New York | — | — |
| Pfizer Investigational Site | Williamsville | New York | — | — |
| Pfizer Investigational Site | Eden | North Carolina | — | — |
| Pfizer Investigational Site | Greensboro | North Carolina | — | — |
| Pfizer Investigational Site | Greenville | North Carolina | — | — |
| Pfizer Investigational Site | Raleigh | North Carolina | — | — |
| Pfizer Investigational Site | Reidsville | North Carolina | — | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | — | — |
| Pfizer Investigational Site | Bellevue | Ohio | — | — |
| Pfizer Investigational Site | Cleveland | Ohio | — | — |
| Pfizer Investigational Site | Clyde | Ohio | — | — |
| Pfizer Investigational Site | Defiance | Ohio | — | — |
| Pfizer Investigational Site | Fostoria | Ohio | — | — |
| Pfizer Investigational Site | Middleburg Heights | Ohio | — | — |
| Pfizer Investigational Site | Orange | Ohio | — | — |
| Pfizer Investigational Site | Toledo | Ohio | — | — |
| Pfizer Investigational Site | Wauseon | Ohio | — | — |
| Pfizer Investigational Site | Westlake | Ohio | — | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | — | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | — | — |
| Pfizer Investigational Site | Eugene | Oregon | — | — |
| Pfizer Investigational Site | Florence | Oregon | — | — |
| Pfizer Investigational Site | Hillsboro | Oregon | — | — |
| Pfizer Investigational Site | Doylestown | Pennsylvania | — | — |
| Pfizer Investigational Site | Harrisburg | Pennsylvania | — | — |
| Pfizer Investigational Site | Hershey | Pennsylvania | — | — |
| Pfizer Investigational Site | Lancaster | Pennsylvania | — | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | — | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | — | — |
| Pfizer Investigational Site | Wormleysburg | Pennsylvania | — | — |
| Pfizer Investigational Site | Greenville | South Carolina | — | — |
| Pfizer Investigational Site | Chattanooga | Tennessee | — | — |
| Pfizer Investigational Site | Knoxville | Tennessee | — | — |
| Pfizer Investigational Site | Memphis | Tennessee | — | — |
| Pfizer Investigational Site | Oak Ridge | Tennessee | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | Annandale | Virginia | — | — |
| Pfizer Investigational Site | Charlottesville | Virginia | — | — |
| Pfizer Investigational Site | Falls Church | Virginia | — | — |
| Pfizer Investigational Site | Norfolk | Virginia | — | — |
| Pfizer Investigational Site | Richmond | Virginia | — | — |
| Pfizer Investigational Site | Bellevue | Washington | — | — |
| Pfizer Investigational Site | Seattle | Washington | — | — |
| Pfizer Investigational Site | Huntington | West Virginia | — | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00134173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 10, 2007 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00134173 live on ClinicalTrials.gov.